Immune to Cancer: The CRI Blog
-
FDA Approves New Cancer Immunotherapy
Merck's new immunotherapy, Keytruda (pembrolizumab), was approved today by the FDA, making it the first PD-1 inhibitor…
-
CRI Names Winners of Top Scientific Prize
Four scientists to be honored with the 2014 Coley Award for their contributions to the discovery of…
-
A Pilgrimage in Spain to Fight All Cancers
Having had four brothers battle cancer, David was inspired to make a 800km fundraising trek a journey…
-
When AIDS Was a Cancer
Before AIDS was recognized as an immune disorder, it was seen as a cancer. Find out what…
-
Two Immunotherapies Clear Important Regulatory Hurdles
The anti-PD-1 drug nivolumab receives the go-ahead for use in Japan, while in the U.S., CAR-T cells…
-
Making Pancreatic Cancer a Target for Immunotherapy
Researchers show that pancreatic cancer, long known to resist immunotherapy, can be made immunogenic after all.
-
How do you help patients find their hope?
Cynthia, an oncology nurse at Mount Sinai Hospital, has a front row seat for immunotherapy. Hear what…
-
Immunotherapy Today: The View from ASCO
Once again, immunotherapy stole the show at the world’s largest annual cancer meeting.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.